32,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
16 °P sammeln
  • Broschiertes Buch

The human immunodeficiency virus (HIV) already infected more than 30 million people worldwide is among the most genetically variable human viruses and is characterized by high rates of replication, mutation, and recombination, presenting a nerve-racking challenge to disease treatment and the development of an efficacious vaccine that can eradicate the virus. As many countries begin to introduce large scale access to anti-HIV drugs (highly active antiretroviral therapy, HAART) to control the disease, ongoing surveillance for HIV drug resistant variants in patients beginning initial…mehr

Produktbeschreibung
The human immunodeficiency virus (HIV) already
infected more than 30 million people worldwide is
among the most genetically variable human viruses and
is characterized by high rates of replication,
mutation, and recombination, presenting a
nerve-racking challenge to disease treatment and the
development of an efficacious vaccine that can
eradicate the virus. As many countries begin to
introduce large scale access to anti-HIV drugs
(highly active antiretroviral therapy, HAART) to
control the disease, ongoing surveillance for HIV
drug resistant variants in patients beginning initial
antiretroviral or experiencing antiretroviral regimen
failure is essential in monitoring treatment
programs. In this book, genetic diversity of HIV and
the profiles of genetic mutations associated with
drug resistance in HIV-infected populations in the
Malaysian capital of Kuala Lumpur were assessed,
leading to the discovery of a novel recombinant virus
Autorenporträt
A budding investigator with inquisitive interest in all aspects
of emerging infectious diseases, particularly in understanding the
evolutionary behaviors of HIV and other human viruses. Recent
pursuits include delineating the origin and migration patterns of
human pathogens and decoding the evolutionary dynamics of
recombinogenic viruses.